Literature DB >> 22948347

[Unclear tetraparesis under immunosupression].

T Kündiger1, R Kober, E Wegjan, T Zöpf.   

Abstract

We report a case of a 69-year-old man who developed tetraparesis and muscular pain under the therapy of prednisolone for several months. Diagnosis was sepsis due to pyomyositis with multiple septic pulmonary staphylococcus aureus abscesses. Antibiotic therapy with piperacillin and tazobactam resulted in a decrease of the inflammatory factors and improvement of the tetraparesis. Pyomyositis, common in tropical areas, is a suppurative infection of striated muscle. Immunodeficiency has been implicated in the development of pyomyositis in temperate climates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948347     DOI: 10.1007/s00108-012-3127-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  6 in total

1.  Pyomyositis caused by methicillin-resistant Staphylococcus aureus.

Authors:  Maria E Ruiz; Seife Yohannes; Christopher G Wladyka
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

2.  A five year analysis of death in accident and emergency room of a semi-urban hospital.

Authors:  A R K Adesunkanmi; A A Akinkuolie; O S Badru
Journal:  West Afr J Med       Date:  2002 Apr-Jun

3.  Pyomyositis.

Authors:  B Gupta; S K Khanna; B K Sharma
Journal:  J Assoc Physicians India       Date:  1980 Mar-Apr

4.  MR imaging of thoracic and abdominal wall infections: comparison with other imaging procedures.

Authors:  H S Sharif; D C Clark; M Y Aabed; O A Aideyan; M C Haddad; T A Mattsson
Journal:  AJR Am J Roentgenol       Date:  1990-05       Impact factor: 3.959

Review 5.  Bacterial pyomyositis in the United States.

Authors:  Nancy F Crum
Journal:  Am J Med       Date:  2004-09-15       Impact factor: 4.965

6.  Pyomyositis: characteristics at CT and MR imaging.

Authors:  B A Gordon; S Martinez; A J Collins
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.